2024-11-25 |
NXGWHYDCSM75052 |
RISING PHARMA HOLDINGS INC |
1193.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-09-28 |
KEONKMNYC240017H |
NORAMCO INC |
5372.0 kg |
293339
|
CHEMICAL INTERMEDIATE RITALINIC ACID. HS CODE. 29333990 |
2024-08-27 |
DSVFHYD8017963 |
AVET PHARMACEUTICALS |
2955.0 kg |
|
PHARMA |
2024-08-27 |
DSVFHYD8017962 |
AVET PHARMACEUTICALS |
2207.0 kg |
|
PHARMA |
2024-07-14 |
EMUIMU24S0010128 |
SPECGX LLC |
2821.0 kg |
293624
|
CHEMICAL INTERMEDIATE D,LTHREORITALINIC ACID . |
2024-06-07 |
SIFKSMUM122571 |
INGENUS PHARMACEUTICALS LLC |
5813.0 kg |
310510
|
ISOSORBIDE MONONITRATE TABLETS UPS |
2024-06-07 |
SIFKSMUM122572 |
INGENUS PHARMACEUTICALS LLC |
6131.0 kg |
310510
|
ISOSORBIDE MONONITRATE ER TABLETS |
2024-06-05 |
SIFKSMUM122519 |
INGENUS PHARMACEUTICALS LLC |
6674.0 kg |
310510
|
ISOSORBIDE MONONITRATE ER TABLETS |
2024-05-25 |
EMUIMU24S0000016 |
CHEMO S A DE C V |
2278.0 kg |
110320
|
VENLAFAXINE HYDROCHLORIDE SR PELLETS 33 TARI . |
2024-05-25 |
EMUIMU23S0042295 |
CHEMO S A DE C V |
2278.0 kg |
271600
|
ELECTRICAL TEMPERATURE CONTROLLER. |
2024-05-18 |
MEDUJ7346243 |
RISING PHARMA HOLDINGS INC |
7128.0 kg |
300490
|
39 PALLETS CONSISTING OF 1 09720 BOTTLES BA CLOFEN T ABLETS, USP 10MG (1000 S C OUNT) B ACLOFEN TABLETS, USP 10MG (100 S COUNT) B A CLOFEN TABLETS, USP 5MG ( 100 S COUNT) BACL OFEN TA BLETS, USP 5MG (100 S COUN T) BACLO FEN TABLETS, USP 5MG (100 S COUNT) INV N O: IN3600000728 DT:29-03-20 24 BUYERS ORDER NO :45000 13919 DT:02-01-2024 BATC H NO:UBCTB4 007A,UBCTB4004A ,UBCTA4003A,UBCTA4002A,UBC TA4001A H.S CODE:3004909 9 SB NO:8767138 DT :30-03 -2024 NET WT: 6348.833 K GS NAC: R ISING PHARMACEU TICALS THE TEMPERATURE TO BE SET AT PLUS 18 DEGREE C ELCIUS IN ACCORDANCE WITH SHIPPER S INSTRUCTION |
2024-05-04 |
SIFKSMUM121626 |
CHETAK NEW YORK LLC |
6081.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTEDRELEASETABLE TS |
2024-05-04 |
SIFKSMUM121622 |
INGENUS PHARMACEUTICALS LLC |
7038.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTED RELEASETABLETS |
2024-05-04 |
SIFKSMUM121624 |
CHETAK NEW YORK LLC |
4923.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTEDRELEASETABLETS |
2024-03-08 |
SIFKSMUM118719 |
INGENUS PHARMACEUTICALS LLC |
7257.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTED RELEASETABLETSUSP |
2024-03-08 |
SIFKSMUM118716 |
INGENUS PHARMACEUTICALS LLC |
6889.0 kg |
930400
|
ISOSORBIDE MONONITRATE EXTENTED RELEASE TABLETSUSP 30MG |
2024-03-08 |
SIFKSMUM118718 |
INGENUS PHARMACEUTICALS LLC |
6704.0 kg |
|
ISOSORBIDE MONONITRATE EXTENTED RELEASETABLETSUSP |
2024-03-08 |
SIFKSMUM118717 |
INGENUS PHARMACEUTICALS LLC |
5683.0 kg |
291229
|
ISOSORBIDE MONONITRATE EXTENTED RELEASETABLE TS USP 30MG |
2023-12-09 |
EMUIMU23S0027994 |
|
2569.0 kg |
292221
|
OMEPRAZOLE DR PELLETSS 8.5. |
2023-11-28 |
SIFKSMUM114815 |
INGENUS PHARMACEUTICALS LLC |
5963.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS |
2023-11-16 |
MOSJS00032093 |
DCS 4277 HGHWAY |
7700.0 kg |
300490
|
HS CODE 30049099 METHOCARBAMOL TABLETS USP 7 . |
2023-11-08 |
SIFKSMUM113573 |
INGENUS PHARMACEUTICALS LLC |
3464.0 kg |
|
ISOSORBIDE MONONITRATE EXTENDED RELEASETABLE TS |
2023-11-05 |
HLCUBO1NIAWXX2AA |
DCS A/C OF ACI HEALTHCARE USA INC |
8896.0 kg |
300490
|
METHOCARBAMOL TABLETS USP, 750MG(500S COUNT) H.S. CODE 30049099 INVOICE NO IN3600000322 DATED 28.09-2023 SB NO. 4268601 DT 29-09-2023 GROSS WEIGHT 8896.172KGS NETT WEIGHT 8056.172KGS NDC NO. 71093-140-05 BATCH NO UMETA3030A, UMETA3028A, UMETA3029A, MFG.DT 09/2023 EXP.DT 08/2026 HBL NO. PSAFL/00111 |
2023-11-02 |
SIFKSMUM113574 |
CHETAK NEW YORK LLC |
18000.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENTED RELEASE TABLETS |
2023-10-27 |
MEDUUI410462 |
HELM DE MEXICO S A |
1603.0 kg |
291631
|
OMEPRAZOLE - TOTAL 325 PACKAGES ONLY (TOTAL THREE HUNDRED TWEN TY FIVE PACKAGES ONLY) T OTAL 30 DRUMS ONLY OMEPR AZOLE DR PELLETS 8.5% H. S.CODE NO: 29163190 GR W T:1603.8 2KGS,NT WT:1500.00 KGS S/BILL NO:3594855 DT :31-AUG-2023 ON BEHALF OF COHANCE LIFESCIENC ES LIMI TED |
2023-10-11 |
SIFKSMUM112543 |
INGENUS PHARMACEUTICALS LLC |
7029.0 kg |
310510
|
ISOSORBIDE MONONITRATE EXTENDED RELEASE TABLETS |
2023-10-11 |
MOSJS00031094 |
DCS 4277 HGHWAY |
10246.0 kg |
300490
|
HS CODE 30049099. METHOCARBAMOL TABLETS USP |
2023-10-11 |
MOSJS00031129 |
DCS 4277 HGHWAY |
8960.0 kg |
300490
|
HS CODE 30049099 METHOCARBAMOL TABLETS USP |
2023-10-02 |
SIFKSMUM112598 |
INGENUS PHARMACEUTICALS LLC |
7537.0 kg |
|
ISOSORBIDE MONONITRATE ERTABLETS |
2023-09-16 |
DSVFHYD8012546 |
AVET PHARMACEUTICALS LABS INC |
4237.0 kg |
|
PHARMA |
2023-09-06 |
MEDUIV982034 |
ACI HEALTHCARE USA INC |
10203.0 kg |
300490
|
METHOCARBAMOL TABLETS USP, 750MG(500S COUNT) H.S. CODE: 30049099 INVOICE N O: IN360000 0181 DATED:21.0 7-2023 SB NO. 2637920 DT : 22-07-2023 NDC 71093-1 41-05 GROSS WEIGTH 10,20 3.848KGS NETT WEIGHT 942 3.848KGS BATCH NO: UM ETB3017A, UMETB3018A, UMET B3019A, UMETB3020 A, MFG DT06/2023 EX P DT 05/2025 THE TEMPERATURE TO BE SET AT PLUS 18 DEGR EE CELCIUS IN ACCORDANCE W ITH SHIPPER S INSTRUCTION |
2023-08-15 |
IMAVFHN062300135 |
AMNEAL PHARMACEUTICALS LLC |
311.0 kg |
291229
|
MECLIZINE HCL USP |
2023-08-10 |
MEDUIV651449 |
ACI HEALTHCARE USA INC |
10193.0 kg |
300490
|
METHOCARBAMOL TABLETS USP, 750MG(500S COUNT) H.S. CODE: 30049099 INVOICE N O: IN360000 0136 DATED:30.0 6-2023 SB NO. 2129473 DT : 30-06-2023 GROSS WEIGH T : 10193.65KGS NE TT WEI GHT : 9413.65KGS NDC NO. 71093-141-0 5 BATCH NO: UMETB3013A, UMETB301 4A, UMETB3015A, UMET B3015A, UMETB3016A, MF G DT06/2023 EXP DT 05/ 2025 THE TEMPERATURE TO BE SET AT PLUS 20 DEGREE CEL CIUS IN ACCO RDANCE WITH SH IPPER S INSTRUCTION |
2023-07-14 |
SIFKSMUM108542 |
INGENUS PHARMACEUTICALS LLC |
7751.0 kg |
310510
|
ISOSORBIDE MONONITRATEEXTENDED RELEASE TABLETS USP30MG |
2023-07-14 |
SIFKSMUM108543 |
INGENUS PHARMACEUTICALS LLC |
7821.0 kg |
|
ISOSORBIDE MONONITRATEEXTENDEDRELEASE TABLETSUSP 30MG |
2023-07-14 |
SIFKSMUM108545 |
INGENUS PHARMACEUTICALS LLC |
3574.0 kg |
291229
|
SOSORBIDEMONONITRATE EXTENDED RELEASETABLETS USP 120MG |
2023-06-10 |
MEDUIU800864 |
CHEMO S A DE C V |
5699.0 kg |
961100
|
TAMSULOSIN HCL - TAMSULOSIN HCL SR PELLETS 0.2% INVOICE NO. IN36000 00567 DT: 27-03-2023 SB NO. 8911746 DT: 29-03-2023 TAMSULOSIN H CL SR PELLE TS 0.2% INVOICE NO. IN36 000005 69 DT: 27-03-2023 SB NO.8909683 DT: 29-03-20 23 TOTAL GROSS WEIGHT 56 99.67KGS TOTAL N ET WEIGH T 5000KGS BATCH NO: DT MPG23023/ DTMPG23024/DTMPG2 3025/ DTMPG23026/DTMPG23 027/DTMPG23028 MFG DATE: FEBRUARY 2023 EX P DATE:J ANUARY 2026 DTMPG23029/D TMPG23030 /DTMPG23031 MFG DATE:MARCH 2023 EXP DAT E :FEBRUARY 2026 DTMPG230 32 MFG DATE:JULY 2022 EXP DATE:JUNE 2025 DTMPG 23033/DTMPG23 035 MFG DAT E:SEPTEMBER 2022 EXP DAT E:AU GUST 2025 |
2023-05-08 |
COSU635458827001 |
LIFESCIENCE LOGISTICS |
8720.0 kg |
310510
|
BACLOFEN TABLETS USP 10MGM20MG (AS PER INVOICE) |
2023-03-20 |
SIFKSMUM104016 |
INGENUS PHARMACEUTICALS LLC |
6556.0 kg |
291229
|
ISOSORBIDE MONONITRATE EXTENDED RELEASETABL ETS USP |